Recurrence: all 3,523 studies

Page 15 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.

• ABT-751 With Chemotherapy for Relapsed Pediatric ALLTerminatedNCT00439296Phase 1/2Results posted
• Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical CancerCompletedNCT00430781Phase 2Results posted
• A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple MyelomaCompletedNCT00429949Phase 2Results posted
• D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous ThromboembolismTerminatedNCT00428441Not applicableResults posted
• Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal CancerCompletedNCT00420381Phase 2Results posted
• Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple SclerosisCompletedNCT00420212Phase 3Results posted
• Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantCompletedNCT00408681Not applicableResults posted
• The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)CompletedNCT00397540Not applicableResults posted
• Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous TherapyCompletedNCT00381940Phase 2Results posted
• Performance of Tension Free Vaginal Mesh (Prolift) Versus Conventional Vaginal Prolapse Surgery in Recurrent Prolapse.CompletedNCT00372190Not applicableResults posted
• Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast CancerCompletedNCT00371345Phase 2Results posted
• A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast CancerCompletedNCT00371254Phase 2Results posted
• Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain MetastasesCompletedNCT00362817Phase 1/2Results posted
• Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00356122Phase 2Results posted
• Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant GliomaCompletedNCT00350727Phase 2Results posted
• Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL)CompletedNCT00336583Phase 2Results posted
• Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.CompletedNCT00334295Phase 2Results posted
• Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDSCompletedNCT00334074Phase 2Results posted
• Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating EfficacyCompletedNCT00330863Phase 4Results posted
• Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic LeukemiaCompletedNCT00328198Phase 2Results posted
• Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian CancerCompletedNCT00316173Phase 2Results posted
• Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell TransplantCompletedNCT00309907Phase 2Results posted
• Study of Dasatinib in Children and Adolescents With Relapsed or Refractory LeukemiaCompletedNCT00306202Phase 1Results posted
• Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With SchizophreniaCompletedNCT00299702Phase 4Results posted
• Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung CancerCompletedNCT00284154Phase 2Results posted
• Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerTerminatedNCT00281879Phase 2Results posted
• Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHLCompletedNCT00274742Phase 1Results posted
• Bevacizumab for Recurrent Malignant GliomaCompletedNCT00271609Phase 2Results posted
• Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - DenosumabCompletedNCT00259740Phase 2Results posted
• MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous TransplantationTerminatedNCT00256776Phase 3Results posted
• Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination TherapyCompletedNCT00256698Phase 3Results posted
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerTerminatedNCT00255684Not applicableResults posted
• Neoadjuvant Imatinib in Dermatofibrosarcoma ProtuberansCompletedNCT00243191Phase 2Results posted
• Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's LymphomaCompletedNCT00238433Phase 2Results posted
• Japan Statin Treatment Against Recurrent Stroke (J-STARS)CompletedNCT00221104Phase 3Results posted
• Pilot Study to Evaluate Escitalopram in Obsessive-compulsive DisorderCompletedNCT00215137Phase 2Results posted
• Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's LymphomaCompletedNCT00201877Phase 2Results posted
• Alemtuzumab to Treat Severe Aplastic AnemiaCompletedNCT00195624Phase 2Results posted
• Haploid Allogeneic Transplant Using the CliniMACS SystemTerminatedNCT00185679Phase 2Results posted
• Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XRCompletedNCT00183274Phase 4Results posted
• Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple MyelomaCompletedNCT00179647Phase 3Results posted
• Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic CancerCompletedNCT00134017Phase 2Results posted
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerCompletedNCT00134004Phase 2Results posted
• Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00118352Phase 2Results posted
• VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.CompletedNCT00116844Phase 4Results posted
• A Study of Aripiprazole in Patients With Major Depressive DisorderCompletedNCT00105196Phase 3Results posted
• Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma Metastatic to the LungCompletedNCT00102531Phase 1/2Results posted
• S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck CancerCompletedNCT00100789Phase 2Results posted
• Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung CancerCompletedNCT00095199Phase 3Results posted
• Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerCompletedNCT00089011Phase 2Results posted
• Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid DisordersCompletedNCT00071396Phase 2Results posted
• Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic AnemiaCompletedNCT00065260Phase 2Results posted
• LMP-specific T-cells for Patients With Relapsed EBV-positive LymphomaCompletedNCT00062868Phase 1Results posted
• CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple MyelomaCompletedNCT00056160Phase 3Results posted
• NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/DisordersCompletedNCT00053989Phase 2Results posted
• Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerCompletedNCT00049504Phase 2Results posted
• Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesCompletedNCT00040846Phase 2Results posted
• Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or NilotinibCompletedNCT00036738Phase 2Results posted
• Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerCompletedNCT00027560Phase 2Results posted
• Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's LymphomaCompletedNCT00003631Phase 2Results posted
• Antineoplaston Therapy in Treating Patients With Recurrent or Refractory OligodendrogliomaTerminatedNCT00003472Phase 2Results posted
• Antineoplaston Therapy in Treating Patients With Low-Grade AstrocytomaTerminatedNCT00003471Phase 2Results posted
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003270Phase 2Results posted
• Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or MalignanciesCompletedNCT00002663Phase 1/2Results posted
• Laparoscopic Transabdominal Preperitoneal Technique in Repair of Recurrent Inguinal HerniaCompletedNCT07926464Not applicable
• Onlay vs. Sublay Mesh Hernioplasty for Primary Ventral HerniaCompletedNCT07896278Not applicable
• Age and Bladder Cancer Outcomes After BCG Treatment: A Multicenter StudyCompletedNCT07798479
• A Study of Treatment Patterns and Annualized Relapse Rate in Multiple Sclerosis Patients Who Escalate Versus Continue Disease-Modifying Therapies Following RelapseCompletedNCT07743281
• To Explore the Influencing Factors and Solutions for Patients With Plaque Psoriasis Undergoing RelapseActive, not recruitingNCT07730619
• Oral Lactobacillus Crispatus Lc-G22 as Adjunctive Therapy for Vulvovaginal CandidiasisCompletedNCT07727967Not applicable
• Relapse and Functional Outcomes in Anti-LGI1 EncephalitisCompletedNCT07722286
• A Clinical Risk Score to Stratify High-risk PanNETsCompletedNCT07695532
• Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective StudyCompletedNCT07657299
• Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain AmyloidosisWithdrawnNCT07626476Early Phase 1
• A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune DiseasesWithdrawnNCT07583030Early Phase 1
• Validation of ESGO Quality Indicators in Advanced Ovarian Cancer SurgeryCompletedNCT07567573
• Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 MutationWithdrawnNCT07566585Phase 1
• Autologous CD19-CD20-NKG2D-nsBicephali CAR-T for Relapsed/Refractory Central Nervous System LymphomaWithdrawnNCT07555561Phase 1
• Adapted RPM-08 for Substance Use Disorder in PakistanCompletedNCT07552623Not applicable
• Guangdong Endometriosis Retrospective Clinical CohortCompletedNCT07519213
• Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to Previous TreatmentsTemporarily not availableNCT07517315
• Holmium Laser Versus Cold Knife Treatment in Urethral StricturesCompletedNCT07505316Not applicable
• Quality of Care for Adolescent and Young Adult (AYA) Patients Living With Serious or Advanced CancerWithdrawnNCT07484282
• Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line TherapyActive, not recruitingNCT07479797Phase 3
• Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia GravisCompletedNCT07472777
• Clinical Study of U29 Injection (CD30-CART) in Patients With CD30-Positive Relapsed/Refractory LymphomaWithdrawnNCT07453446Phase 1
• A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic LeukemiaWithdrawnNCT07428486Phase 1
• Italian Real-World Study of Epcoritamab in Relapsed or Refractory DLBCLActive, not recruitingNCT07393204
• CRUCIAL-R Study : Cruciferous Vegetables Dietary Regimen in NMIBCActive, not recruitingNCT07391137Not applicable
• A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid TumorsActive, not recruitingNCT07387874
• Comparison of Pathological Outcome and Recurrence Rate Between En Bloc and Conventional Transurethral Resection of Bladder TumorCompletedNCT07347132Not applicable
• the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune DiseasesActive, not recruitingNCT07339540Early Phase 1
• Safety and Efficacy of the 3DMax™ MID Anatomical Mesh (BD, USA) in Laparoscopic-endoscopic Inguinal Hernia RepairActive, not recruitingNCT07289802
• Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.CompletedNCT07224737
• Life-Skills Training Program: Its Effect on Self-efficacy Among Patients With Substance Use DisordersCompletedNCT07174960Not applicable
• Actinium Therapy for Late-stage Aggressive SarcomasActive, not recruitingNCT07156565Phase 1
• Real-life Efficacy and Toxicity of Brentuximab-Vedotin Associated With Bendamustine in Patients With Relapsed or Refractory Hodgkin Lymphoma (HL-R2-B2)CompletedNCT07145125
• A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic LeukemiaActive, not recruitingNCT07134088Phase 1/2
• Engineered T-Cell Therapy for Patients With ALPP-Positive Advanced Solid TumorsTerminatedNCT07123493Early Phase 1
• Autoinflation as a Eustachian Tube RehabilitationCompletedNCT07122999Not applicable

← Recurrence overview